Thomas Jefferson University Hospital
 
News Releases
Jefferson Radiation Oncologist Re-elected to Chair Prestigious Clinical Trials Group

Related Links

Radiation Oncology

News Archive

Featured in the Media

JeffNEWS


Walter J. Curran Jr., M.D., professor and chair of radiation oncology at Jefferson Medical College at Thomas Jefferson University in Philadelphia and clinical director of Jefferson’s Kimmel Cancer Center, has been re-elected to a third four-year term as Group Chair of the Radiation Therapy Oncology Group (RTOG), a Philadelphia-based federally funded cancer clinical trials group that carries out multi-disciplinary research nationwide and in Canada.

As Group Chair, Dr. Curran serves as chief scientific leader of the organization, in addition to its administrator. He also is principal investigator of two major National Cancer Institute-funded grants awarded to RTOG to support a number of clinical trials, in addition to the organization’s Community Clinical Oncology Program (CCOP). CCOP provides communities with the latest cancer prevention and treatment research findings through participation in clinical trials.

Dr. Curran, one of only four Group Chairs in the organization’s 35 years of existence, looks forward to his ongoing leadership role.

“RTOG continues to conduct landmark trials and establish new standards of care for brain tumors and for cancers of the head and neck, lung, gastrointestinal tract and prostate,” says Dr. Curran. “The coming years will be exciting.”



Media Only Contact:
Steven Benowitz
Thomas Jefferson University Hospital
Phone: 215-955-6300

Published: 3-1-2005